Clinical Trials
- Liver
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
- Ages18 years and older
- GenderBoth
- Date09/18/2017
- Lung Cancer
A Biomarker-directed Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy
- Date10/20/2020
- Brain and Other Nervous System Cancers, Pediatric Cancers
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
- Date11/04/2020
- Digestive System, Endocrine System
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
- Ages18 years - 85 years
- GenderBoth
- Date03/01/2020
- Phase 1 Cancers
A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers
- Date12/22/2020
- Phase 1 Cancers
A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1042 in Subjects With Malignant Solid Tumors
- Date10/08/2020
- Phase 1 Cancers
A First-In-Human, Phase 1/2 Study Of CFI-402411, a Hematopoietic Progenitor Kinase-1 (HPK1) Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies
- Date04/13/2021
- Phase 1 Cancers
A First-in-human, Two-part Clinical Study to Assess the Safety, Tolerability and Activity of IV Doses of ICT01 as Monotherapy and in Combination With a Checkpoint Inhibitor, in Patients With Advanced-stage, Relapsed/Refractory Cancer
- Date02/22/2021
- Kidney & Urinary Tract
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients (STAGED-PKD)
- Ages18 years - 50 years
- GenderBoth
- Date04/18/2019
- Lymphoma
A Multi-center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects With Relapsed and/or Refractory Diffuse Large B Cell Lymphoma
- Date07/02/2021